Clinical Trials on Normal Human Plasma Level of iNOS in India
Total 0 results
Nothing found
Sponsors and Collaborators
- Rivierduinen, Centre for Personality disorders Jelgersma
- 904 Hospital of the People's Liberation Army Joint Logistic Support Force
- Eurotrials Brasil Consultores Cientificos Ltda
- Foundation for Biosanitary Research and Innovation in Primary Health Care
- Foshan Sanshui District People's Hospital
- Cardiovascular Center Dedinje, Belgrade, Serbia
- Lilly PharmaceuticalCompany
- Korea Otsuka International Asia Arab
- Iyad Naeem Muhammad, PhD
- Klinik für Allgemein- und Viszeralchirurgie, Department Chirurgie, Luzerner Kantonsspital
- University of Applied Sciences Jena
- Oblikue Consulting
- United States Department of Defense (DOD)
- Paulo Sérgio Gomes Nogueira Borges
- Plethora Solutions Ltd
- Gunkang Pharmaceuticals, Inc
- Julian Taylor Green
- Arsha Vidya Tirtha
- Sudimplant SAS - Groupe TBR
- S-Biotek Holding ApS
- View Full List
Medical Conditions
- Gray Platelet Syndrome
- Post-discharge Pharmacist Counseling to Prevent Readmissions
- Puberty, Delayed
- Advance Directive Completion
- Serum Albumin Low
- Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8
- Brain Tumor, Primary
- Thyroid and Parathyroid Surgery
- Chemotherapy-Induced Neutropenia
- Anemia Acute
- Blepharospasm of Both Eyelids
- Relapsed or Refractory Chronic Lymphocytic Leukemia (Including Small Lymphocytic Lymphoma)
- Vibration; Exposure
- Deformity Flexion
- Testicular Teratoma
- Visual Attention Span Deficit
- Immunologically-induced Lung Disease
- Malaria,Falciparum
- Huntington Chorea
- Hypothermia Following Anesthesia, Sequela
- View Full List
Drug Interventions
- Celecoxib
- Cytisine
- Mineralocorticoid receptor antagonist
- Pemetrexed
- Cyanoacrylate
- Furmonertinib 160 mg
- MMV390048 120mg
- Sorafenib
- Ebselen
- Rovalpituzumab tesirine
- Oxycodone
- Acalabrutinib in combination with VR
- Standard medical therapy
- Pegfilgrastim
- S-Adenosyl-Methionine
- Vosaroxin
- Bimatoprost 0.03% eye drops
- F520
- ABY-035 i.v.
- Recombinant monoclonal antibody against human epidermal growth factor receptor injection (HS627)
- View Full List
CROs by country
- Contract Research Organizations in Azerbaijan
- Contract Research Organizations in China
- Contract Research Organizations in Congo, DR of
- Contract Research Organizations in Croatia
- Contract Research Organizations in Indonesia
- Contract Research Organizations in Israel
- Contract Research Organizations in Kyrgyzstan
- Contract Research Organizations in Lebanon
- Contract Research Organizations in Luxembourg
- Contract Research Organizations in Morocco
- Contract Research Organizations in Ukraine
- Contract Research Organizations in Uruguay
- Contract Research Organizations in Venezuela
- CRO list by country